Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.48 |
| ▸ | PRKCG | P05129 | 2/20 | 0.48 |
| ▸ | PRKCB | P05771 | 2/20 | 0.48 |
| ▸ | PRKCA | P17252 | 2/20 | 0.48 |
| ▸ | PRKCH | P24723 | 2/20 | 0.48 |
| ▸ | PRKCI | P41743 | 2/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.48 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.48 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.48 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.48 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.47 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.47 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8638519 | 1.00 | PRKD3 (0.48) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL5512431 | 0.93 | LPAR1 (0.53) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL5512423 | 0.93 | LPAR1 (0.53) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL2233937 | 0.90 | PLA2G2A (0.47) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8917115 | 0.89 | PLA2G2A (0.56) | LPAR1LPAR3LPAR2PLA2G2APLA2G10 | |
| SCHEMBL9137670 | 0.89 | PLA2G2A (0.56) | LPAR1LPAR3LPAR2PLA2G2APLA2G10 | |
| SCHEMBL497520 | 0.89 | PLA2G2A (0.56) | LPAR1LPAR3LPAR2PLA2G2APLA2G10 | |
| SCHEMBL8979451 | 0.87 | PLA2G2A (0.54) | LPAR1LPAR3LPAR2PLA2G2APLA2G10 | |
| SCHEMBL9539505 | 0.87 | LTB4R (0.38) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10933731 | 0.86 | PLA2G2A (0.43) | PLA2G2APLA2G10PLA2G1BPLA2G5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040047903-A1 | D and L etherlipid stereoisomers and liposomes | ELAN PHARMACEUTICALS, INC. | 2004-03-11 | — | — | US | disclosed |
| US-6667053-B1 | Liposome having lipid bilayer comprising optically active ether lipid anti-cancer agent component, underivatized phosphatidylcholine, sterol, and phosphatidylethanolamine linked to dicarboxylic acid at ethanolamine group | ELAN PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040047903-A1 | D and L etherlipid stereoisomers and liposomes | DEGS1, DLD, PLD2 | PRKD3 555/4885PRKCG 1943/4885PRKCB 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.